SecBot SecBot
Insider Buy ·Filed Aug 27, 2026

IMTX

Immatics N.V.
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago SEC0001193125-26-371237
Insider cluster: 1 insiders, $7.5M total
Actionable Insight ▲ Bullish

This is a strong conviction buy from a sophisticated healthcare investor with board representation. The $7.5M purchase at 0.58% of market cap is a material signal. Watch for upcoming pipeline catalysts or partnership announcements that could validate this insider's thesis.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$9.45
T+0 close · Aug 27, 2026 · via day close
Latest settled
−10.05%
T+20 · $8.50 · next T+60 in 6d
Vs SPY
−10.31%
α at T+20
Latest observation
−27.66%
T+55 · FF3 residual α
  1. T+0 · Aug 28 $9.45entry
  2. T+1 · 3mo ago +0.85%α +1.15% · $9.53
  3. T+5 · 2mo ago +1.16%α +1.05% · $9.56
  4. T+20 · 7w ago −10.05%α −10.31% · $8.50
  5. T+55 · todayOpen
  6. T+60 · in 6d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Perceptive Advisors LLC purchased 863,060 shares of Immatics N.V. for $7.5M at $8.69/share in a single open-market transaction. This is a large, conviction buy by a healthcare-focused investment firm that is also a director, representing approximately 0.58% of the company's $1.3B market cap.

Key Financial Metrics

Direction
buying
Total Value
$7.5M
Insiders
1

Key Facts

  • Director Perceptive Advisors LLC purchased 863,060 shares at $8.69/share for a total of $7.5M
  • The purchase represents ~0.58% of IMTX's $1.3B market cap
  • This is the only insider trade in the last 30 days, and the only trade in the last 7-day cluster window
  • The buyer is a healthcare-focused investment firm with a board seat, making this a high-conviction signal
  • IMTX has 94% analyst bullishness (15 Buy, 1 Hold, 0 Sell)

Financial Impact

Director purchased $7.5M of stock at $8.69/share, representing 0.58% of market cap

insider ownershipmarket perception

Risk Factors

  • Single insider trade, even by a director, may not be as predictive as a C-suite cluster
  • Biotech stock volatility could overwhelm the signal from this purchase

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001193125-26-371237

Track record

23 reports on IMTX

Performance horizon

7 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +22.12% at T+20 after the May 12, 2026 report. 8 of 13 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $6.24 Now $6.17 −1.12% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $6.55 Now $6.17 −5.73% settles Nov 23
  3. Nov 10, 20266d ago 6-K Neutral 5/10 No price data
  4. Nov 10, 20266d ago Press Release Neutral 4/10 Entry $6.42 Now $6.17 −3.89% settles Nov 17
  5. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $7.15 to $7.20 Now $6.17 −13.71% ▲ +0.70% +1.96% vs SPY
  6. Oct 24, 202624d ago Press Release Bullish 6/10 Entry $7.15 to $7.20 Now $6.17 −13.71% ▲ +0.70% +1.96% vs SPY
  7. Oct 23, 202624d ago 6-K Bullish 7/10 Entry $7.31 to $7.20 Now $6.17 −15.60% ▼ −1.50% −0.95% vs SPY
  8. Aug 27, 202611w ago Insider Buy Bullish 6/10 Viewing Entry $9.45 to $9.56 Now $6.17 −34.71% ▲ +1.16% +1.05% vs SPY
  9. Aug 26, 202611w ago 6-K Bearish 6/10 Entry $9.36 to $9.46 Now $6.17 +34.08% ▼ −1.07% −0.80% vs SPY
  10. Aug 18, 202612w ago 6-K Neutral 6/10 Entry $9.09 to $9.24 Now $6.17 −32.12% ▲ +1.65% +1.85% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 27, 2026